Glycogene Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
250
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$14.9M
- Investors
-
10
Glycogene General Information
Description
Manufacturer of biotechnology products intended for nucleic acid and glycan-related development. The company utilizes a proprietary chemo-enzymatic synthesis platform and fermentation technologies to produce nucleosides, nucleotides, phosphoramidites, carbohydrates, enzymes, and diagnostic reagents, providing the biotechnology and pharmaceutical industries with raw materials for RNA research and product commercialization.
Contact Information
Website
www.cn.glycogene.comCorporate Office
- 9th Floor, Building 3, Wuhan Precision Medicine Industrial Base
- Number 9, Gaokeyuan Third Road, East Lake High-tech Development Zone
- Wuhan, Hubei 430074
- China
Corporate Office
- 9th Floor, Building 3, Wuhan Precision Medicine Industrial Base
- Number 9, Gaokeyuan Third Road, East Lake High-tech Development Zone
- Wuhan, Hubei 430074
- China
Glycogene Timeline
Glycogene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 22-Sep-2026 | $14.9M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 02-Feb-2026 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 02-Feb-2026 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 14-Aug-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 16-Jul-2025 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 16-Jul-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 04-Mar-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Mar-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 29-Oct-2021 | Completed | Generating Revenue |
Glycogene Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Glycogene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Glycogene Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fengnian Capital | Venture Capital | Minority | ||
| CICC Capital | PE/Buyout | Minority | ||
| Lucion Venture Capital | Venture Capital | Minority | ||
| Wuxi AstraZeneca CICC Venture Capital Partnership | Venture Capital | Minority | ||
| Huaxin Capital | Venture Capital | Minority |
Glycogene FAQs
-
When was Glycogene founded?
Glycogene was founded in 2019.
-
Where is Glycogene headquartered?
Glycogene is headquartered in Wuhan, China.
-
What is the size of Glycogene?
Glycogene has 250 total employees.
-
What industry is Glycogene in?
Glycogene’s primary industry is Biotechnology.
-
Is Glycogene a private or public company?
Glycogene is a Private company.
-
What is Glycogene’s current revenue?
The current revenue for Glycogene is .
-
How much funding has Glycogene raised over time?
Glycogene has raised $29.2M.
-
Who are Glycogene’s investors?
Fengnian Capital, CICC Capital, Lucion Venture Capital, Wuxi AstraZeneca CICC Venture Capital Partnership, and Huaxin Capital are 5 of 10 investors who have invested in Glycogene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
